|Home||Internet of Things||Aerospace||Apparel||Energy||Defense||Health Care||Logistics||Manufacturing||Retail|
VeriChip RFID Technology Gets FDA Approval; Stock Surges
Subdermal human RFID-tagging VeriChip won FDA approval yesterday, marking a moment of vindication for the heretofore controversial product.
Oct 13, 2004—This article was originally published by RFID Update.
October 13, 2004—VeriChip technology, in which an RFID tag encoded with personal information is implanted under its user's skin, won approval from the U.S. Food and Drug Administration yesterday as a patient identification mechanism in healthcare situations. Such official validation marks a moment of vindication for the heretofore controversial product. Derided by privacy advocates as Orwellian and Seventh-day Adventists as the Mark of the Beast, VeriChip has nonetheless continued to grab headlines and gain traction in the marketplace: in July, Mexico's attorney general announced that he and his staff had accepted the chip to enhance authentication, and in Barcelona, a popular discotheque incents club-goers to "get chipped" in order to access its VIP lounge and make cashless purchases. Predictably, the stock of VeriChip-maker Applied Digital Solutions soared on the news.
Read the article at CBS.MarketWatch.com
Login and post your comment!
Not a member?
Signup for an account now to access all of the features of RFIDJournal.com!
SEND IT YOUR WAY
RFID JOURNAL EVENTS
ASK THE EXPERTS
Simply enter a question for our experts.
|RFID Journal LIVE!||RFID in Health Care||LIVE! LatAm||LIVE! Brasil||LIVE! Europe||RFID Connect||Virtual Events||RFID Journal Awards||Webinars||Presentations|